Stocks / NASDAQ / China Biologic Products Holdings, Inc.

China Biologic Products Holdings, Inc.

Our Opinion

China Biologic Products Holdings, Inc. is on the Cruelty Free Investing use of animals list because they conduct Pre-clinical studies of their drugs on animals to assess a product’s safety profile.

Supporting Evidence:

The company stated in its Annual report of 2016 that they, “Completed the official virus inactivation by the PRC National Institutes for Food and Drug Control. Completed the animal experiments for safety and effectiveness. ” (Page 17) Read the full document.

Company Description

China Biologic Products Holdings, Inc. operates as a biopharmaceutical company, which engages in the manufacture and distribution of plasma-based pharmaceutical products and other biological substances. Its products include human albumin, human immunoglobulin for intravenous injection, human Hepatitis B immunoglobulin, human rabies immunoglobulin, human immunoglobulin, human coagulation factor VIII, human prothrombin complex concentrate, and placenta polypeptide. The company was founded on December 20, 1989 and is headquartered in Beijing, China. [Source: MarketWatch]

Company Website: